CannaCAST IL Heli Dangur, Narkis Tessler

MyCrops have developed a vision diagnostics platform that uses algorithms, AI & deep learning to remotely identify hot spots of potential plant health issues and to determine optimal plant maturity. Additional platform features provide a significant increase in the bottom line. In today’s CannaCAST IL episode, Assaf Gavish, co-founder, and CSO of MyCrops introduces the platform and its many benefits.

Cultivators interested in learning more about MyCrops, as well as potential investors are invited to reach out to Assaf at: assafg@mycrops.ag , MyCrops website: https://www.mycrops.ag/

Grow Director, led by Dima Chernobilsky, Co-Founder & CEO, have simplified and automated the process of growing medical grade cannabis to enable consistent growing of your optimal growth protocol, with minimal intervention so that you can start the system and come back only when the entire growth cycle is complete. Grow Director’s platform also includes a community feature that enables home-growers to share their protocols and knowledge.
Potential distributors who are cannabis insiders in their markets, as well as potential investors are invited to reach out to Dima at: dima@growdirector.com , Grow Director website: https://growdirector.com/

GemmaCert, led by Guy Setton, PhD., Co-Founder & CEO, has disrupted the cannabis testing industry with a portable, user-friendly & affordable device for testing cannabis potency that provides results in under 5 minutes. GemmaCert devices have been sold in 30 countries on 6 continents – setting the standard for diagnostic on-site solutions. Guy offers us insights into the key success factors that enabled their success.

Potential distributors who are cannabis insiders in their markets, as well as potential investors are invited to reach out to Guy at guy.setton@gmail.com, GemmaCert website: https://gemmacert.com/

Today we host Yaron Shoob, Founder and CEO of Elixie SL. Yaron and his team have solved the challenges of both rapid onset and high bioavailability without smoking or vaping – Elixie SL’s Personalized Sublingual Delivery System. The Elixie SL device utilizes a dynamic release mechanism in which the rate of release is determined by the individual’s personal anatomy.
Potential investors or strategic partners looking to collaborate are invited to reach out to Yaron at: yaron@elixie.tech, Elixie SL website: https://www.elixie.tech/

Today we interviewed Moav Gafni, Co-founder and Business Development Manager of Cannabotech, a biopharmaceutical company with a focus on the prevention and treatment of cancer, chronic pain and inflammation using botanical elements from medicinal mushrooms and cannabinoids.
Everything about Cannabotech is innovative – their wellness products, their personalization technology, their pharmaceutical formulas, and wearable medical device, and even their capital-raising strategy!
Moav invites potential strategic partners, research collaboration partners, distributors, and potential investors to reach out at Moav@Cannabotech.com Cannabotech website: https://www.cannabotech.com/

Today we host Dr. Kobi Buxdorf, Founder and CEO of Cannadorf. Kobi reveals to us how Cannadorf is able to sidestep all growing obstacles and manufacture cannabis in a closed biological environment to produce sterile, all-natural, full-spectrum pharma-grade cannabis, with consistently identical profiles every single time.

Potential pharma companies or cannabis-based drug developers looking to collaborate are invited to reach out to Kobi at kobi@cannadorf.com, Cannadorf website: https://cannadorf.com/